Key takeaways from ASCO® 2026
July 16, 2026 |
Following ASCO® 2026, Inizio’s experts have shared their perspectives across three thought leadership articles, each exploring a different aspect of what this year’s congress revealed for pharmaceutical organisations. Together, they examine the evolving role of congresses, from experience design and technology to strategy, measurement and commercial impact.
What the best congress experiences got right at ASCO® 2026
Simon Davenport, Global Head of Environments at Inizio Engage, explores the characteristics that set the most successful congress experiences apart. Drawing on observations from the exhibition floor, the article highlights three key principles: creating a clear and consistent scientific narrative, designing interactions that genuinely enhance engagement rather than relying on technology for its own sake, and building flexible experiences that allow HCPs to engage at different levels. The article explains why thoughtful experience design is becoming increasingly important as congress environments grow more competitive.
Read full article here.
What ASCO® 2026 revealed about the future of pharma congress engagement
Nick Bellomo, VP of Experience and Technology at Inizio Medical, examines the technology and engagement innovations that stood out across ASCO® 2026. From immersive LED environments and AI-powered interactions to tactile, low-tech activations, the article explores how organisations are rethinking the use of technology to create more meaningful scientific engagement. It concludes that the most effective congress experiences combine creativity with purposeful design to strengthen scientific communication and generate valuable behavioural insights.
Read full article here.
ASCO® 2026: Why a connected approach is key to congress success
Lynsey Holbrook, Global Client Development Director at Inizio Engage, focuses on the growing complexity of congress planning and the challenge of demonstrating return on investment. The article explores why many pharmaceutical organisations struggle to connect strategy, execution and measurement, despite increasing investment in congresses. It outlines how a more connected approach can help teams align stakeholders, create more coordinated delegate experiences and measure the activities that drive meaningful scientific and commercial outcomes.
Read full article here.
This content was provided by Inizio
Company Details
Latest Content from Inizio
PEGASUS SCOOPS EXCELLENCE IN INTEGRATED PRODUCT/BRAND COMMUNICATIONS AT COMMUNIQUÉ 2017
Pegasus, an Ashfield company, part of UDG Healthcare plc, is delighted to have won the Excellence In Integrated Product/Brand Communications award at the 2017 Communiqué awards for its work with…
EphMRA 2017 round up
We were delighted to present, exhibit and sponsor this year’s EphMRA Annual Conference in Amsterdam, Netherlands.
Taking a hybrid qualitative-quantitative approach to research
Directors Phil Rosenberg and Chris Gaj discuss ways to achieve qualitative insights with quantitative precision and the benefits of a hybrid approach.Watch the video: https://www.researchpartnership.com/news/2017/06/video-taking-a-hybrid-qualitative-quantitative-appr…
20th anniversary celebrations
We recently celebrated our 20th year anniversary with parties for our employees across the globe.Find out more and view the photos https://www.researchpartnership.com/news/2017/06/20th-anniversary-party-photos/
Pharma CI Asia Conference & Exhibition 2017
13-14 July 2017, Singapore
Director Richard Head is joint winner of the 2017 EphMRA President’s Award
We are delighted to announce that Research Partnership’s Richard Head is joint winner of the 2017 EphMRA President’s Award for his contribution to pharmaceutical market research
Forever Angels founder is awarded an MBE
We are delighted to announce that Forever Angels founder Amy Hathaway has been awarded an MBE in this year’s Queen’s Birthday Honours list for providing interim and community care to…
Research Partnership’s Singapore team relocates to new office
We are delighted to announce that our Asia-Pacific team in Singapore has relocated to new premises.
Nutrition Market in Brazil: Growth Against the Odds
Published in eyeforpharma June 2017 by Marc Yates
Research Partnership launches new patient Living with Ulcerative Colitis (UC) US report
Living with Ulcerative Colitis (UC) is a study conducted amongst 100 adult UC patients in the US. The study employs a mixed quantitative/qualitative methodology and will be available to purchase…